Novarex Co Ltd
KOSDAQ:194700
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
6 680
22 000
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Novarex Co Ltd
Operating Income
Novarex Co Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
Novarex Co Ltd
KOSDAQ:194700
|
Operating Income
â‚©31.7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
AmorePacific Corp
KRX:090430
|
Operating Income
â‚©335B
|
CAGR 3-Years
16%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-7%
|
|
|
Amorepacific Group
KRX:002790
|
Operating Income
â‚©363B
|
CAGR 3-Years
19%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-8%
|
|
|
Cosmax Inc
KRX:192820
|
Operating Income
â‚©195.4B
|
CAGR 3-Years
31%
|
CAGR 5-Years
23%
|
CAGR 10-Years
20%
|
|
|
LG H&H Co Ltd
KRX:051900
|
Operating Income
â‚©346.7B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-5%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Operating Income
â‚©223.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
19%
|
CAGR 10-Years
15%
|
|
Novarex Co Ltd
Glance View
NOVAREX Co., Ltd. engages in the manufacture and sale of dietary supplements. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2018-11-14. is a Korea-based company principally engaged in the manufacturing and distribution of health functional foods. The firm manufactures and sells nutritional supplement products containing vitamins and minerals; individual recognition products which are helpful for body fat reduction, eye health, and joint health; lactic acid bacteria containing products used for skin condition improvement. The firm also produces and sells coenzyme Q10 products, wild mango seed extract products, spirulina products, as well as others. The firm distributes its products within domestic market to overseas markets.
See Also
What is Novarex Co Ltd's Operating Income?
Operating Income
31.7B
KRW
Based on the financial report for Jun 30, 2025, Novarex Co Ltd's Operating Income amounts to 31.7B KRW.
What is Novarex Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
8%
Over the last year, the Operating Income growth was 31%. The average annual Operating Income growth rates for Novarex Co Ltd have been -1% over the past three years , 8% over the past five years .